Cyclacel Pharmaceuticals, Inc. (CYCC) : long-term investment. Buy price 3.16-3.25$. Target is 7 $.....NASDAQ expected target is 10$...one of the undervalued stocks in NASDAQ(actually number one undervalued stock)...Community rating: Bullish....Phase 3 trial for lymphoma treatment
http://investor.cyclacel.com/release...leaseID=851601
